FCGR2A and cancer: Interestingly, CD32-CR T cell anti-cancer activity was neither affected by human AB serum (10–30% concentration), as shown by the reduced crystal violet staining of adherent MDA-MB-468 cells (Fig 3D), nor by human IgGs (Fig 3E).